Private Capital Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
DSA
Private Capital Group's DGX Position: Q2 2022 in Review
Private Capital Group reduced its Quest Diagnostics (DGX) stake by 35% in Q2 2022, selling an estimated $13.1K and leaving 181 shares worth $24K. The position accounts for 0.02% of the portfolio, ranked #767.
Private Capital Group first reported a position in DGX in Q4 2017 and has held it in 19 quarters since. The position peaked at $116K in Q4 2017. 850 funds tracked by Wall St. Rank hold DGX as of Q2 2022.
- Private Capital Group held 181 shares of Quest Diagnostics worth $24K as of Q2 2022.
- Private Capital Group sold 96 Quest Diagnostics shares in Q2 2022, an estimated $13.1K.
- Quest Diagnostics made up 0.02% of Private Capital Group's portfolio in Q2 2022, its #767 holding.
- Private Capital Group first reported a position in Quest Diagnostics in Q4 2017 and has held it in 19 quarters since.
- Private Capital Group's Quest Diagnostics position peaked at $116K in Q4 2017.
- 850 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2022.
Based on Private Capital Group's 13F filing for Q2 2022, filed 28 Jul 2022.